FDA Inspection
Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding PharmacyAnderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy – FDA Inspection, Apr 5, 2019
Record Details
This FDA Inspection record concerns Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy, with an inspection on April 5, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 5, 2019
- Product Type
- Drugs
View Company Profile
ID · 75f49936-c24b-4474-ba32-16d5855e1045
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1085801
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- Warning Letter
FDA Citations
4- FDCA 501(a)(2)(A)Non-microbial contamination, production area
- FDCA 501(a)(2)(A)Cleanliness, ISO-classified areas
- FDCA 501(a)(2)(A)Ceiling tiles, cleanroom
- FDCA 501(a)(2)(A)Hazardous drugs, prevention of cross-contamination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 9, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy
- FDA Inspection 1153267 - 2021-09-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.